Jiangsu Sihuan Bioengineering Co Ltd (000518) - Total Liabilities
Based on the latest financial reports, Jiangsu Sihuan Bioengineering Co Ltd (000518) has total liabilities worth CN¥123.67 Million CNY (≈ $18.10 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Jiangsu Sihuan Bioengineering Co Ltd - Total Liabilities Trend (1992–2024)
This chart illustrates how Jiangsu Sihuan Bioengineering Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See Jiangsu Sihuan Bioengineering Co Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Jiangsu Sihuan Bioengineering Co Ltd Competitors by Total Liabilities
The table below lists competitors of Jiangsu Sihuan Bioengineering Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Kolon Corp
KO:002020
|
Korea | ₩4.72 Trillion |
|
Taier Heavy Industry Co Ltd
SHE:002347
|
China | CN¥1.16 Billion |
|
Evolent Health Inc
NYSE:EVH
|
USA | $1.48 Billion |
|
IEI Integration Corp
TW:3022
|
Taiwan | NT$3.95 Billion |
|
Shutterstock
NYSE:SSTK
|
USA | $774.90 Million |
|
Ooma Inc
NYSE:OOMA
|
USA | $130.97 Million |
|
Hunan Resun Co Ltd
SHE:001218
|
China | CN¥802.14 Million |
|
WHA UTILITIES AND PO
BK:WHAUP-R
|
Thailand | ฿17.49 Billion |
Liability Composition Analysis (1992–2024)
This chart breaks down Jiangsu Sihuan Bioengineering Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Jiangsu Sihuan Bioengineering Co Ltd.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.45 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.34 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.24 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Jiangsu Sihuan Bioengineering Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Jiangsu Sihuan Bioengineering Co Ltd (1992–2024)
The table below shows the annual total liabilities of Jiangsu Sihuan Bioengineering Co Ltd from 1992 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥168.43 Million ≈ $24.65 Million |
+13.65% |
| 2023-12-31 | CN¥148.19 Million ≈ $21.69 Million |
+2.50% |
| 2022-12-31 | CN¥144.58 Million ≈ $21.16 Million |
-5.21% |
| 2021-12-31 | CN¥152.54 Million ≈ $22.32 Million |
+10.01% |
| 2020-12-31 | CN¥138.66 Million ≈ $20.29 Million |
-45.73% |
| 2019-12-31 | CN¥255.51 Million ≈ $37.39 Million |
-9.74% |
| 2018-12-31 | CN¥283.07 Million ≈ $41.42 Million |
+10.54% |
| 2017-12-31 | CN¥256.08 Million ≈ $37.47 Million |
-36.97% |
| 2016-12-31 | CN¥406.26 Million ≈ $59.45 Million |
+79.89% |
| 2015-12-31 | CN¥225.84 Million ≈ $33.05 Million |
+134.05% |
| 2014-12-31 | CN¥96.49 Million ≈ $14.12 Million |
+5.10% |
| 2013-12-31 | CN¥91.81 Million ≈ $13.43 Million |
+11.13% |
| 2012-12-31 | CN¥82.61 Million ≈ $12.09 Million |
+52.49% |
| 2011-12-31 | CN¥54.17 Million ≈ $7.93 Million |
-34.19% |
| 2010-12-31 | CN¥82.32 Million ≈ $12.05 Million |
+104.18% |
| 2009-12-31 | CN¥40.32 Million ≈ $5.90 Million |
-51.55% |
| 2008-12-31 | CN¥83.21 Million ≈ $12.18 Million |
+68.10% |
| 2007-12-31 | CN¥49.50 Million ≈ $7.24 Million |
-77.23% |
| 2006-12-31 | CN¥217.36 Million ≈ $31.81 Million |
-25.70% |
| 2005-12-31 | CN¥292.56 Million ≈ $42.81 Million |
+3.59% |
| 2004-12-31 | CN¥282.43 Million ≈ $41.33 Million |
+109.93% |
| 2003-12-31 | CN¥134.53 Million ≈ $19.69 Million |
+63.28% |
| 2002-12-31 | CN¥82.39 Million ≈ $12.06 Million |
-16.69% |
| 2001-12-31 | CN¥98.90 Million ≈ $14.47 Million |
+41.62% |
| 2000-12-31 | CN¥69.84 Million ≈ $10.22 Million |
+16.63% |
| 1999-12-31 | CN¥59.88 Million ≈ $8.76 Million |
-21.24% |
| 1998-12-31 | CN¥76.03 Million ≈ $11.13 Million |
-30.43% |
| 1997-12-31 | CN¥109.29 Million ≈ $15.99 Million |
+17.06% |
| 1996-12-31 | CN¥93.36 Million ≈ $13.66 Million |
+78.10% |
| 1995-12-31 | CN¥52.42 Million ≈ $7.67 Million |
-3.98% |
| 1994-12-31 | CN¥54.59 Million ≈ $7.99 Million |
+24.43% |
| 1993-12-31 | CN¥43.88 Million ≈ $6.42 Million |
-26.14% |
| 1992-12-31 | CN¥59.40 Million ≈ $8.69 Million |
-- |
About Jiangsu Sihuan Bioengineering Co Ltd
Jiangsu Sihuan Bioengineering Co., Ltd. engages in the pharmaceutical business in China. It offers delusheng and xindelusheng, an anti-tumor biotherapeutic drug for the treatment of kidney cancer, malignant melanoma, and cancerous chest and abdominal mass. It also engages in breeding and sales of flowers and seedlings; and landscaping projects. Jiangsu Sihuan Bioengineering Co., Ltd. was founded … Read more